A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period
Clinical trial NCT05002933 · COMPLETED
Trial details
- NCT number
- NCT05002933
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2023-02-24
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.